Related content

Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase Levels

By  

Digestion, Vol. 65, Iss. 2, 2002-05 ,pp. : 127-130

Karger

Access to resources Recommend Favorite

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

By Gramenzi Annagiulia   Andreone Pietro   Cursaro Carmela   Verucchi Gabriella   Boccia Sergio   Giacomoni Pier Luigi   Galli Silvia   Furlini Giuliano   Biselli Maurizio   Lorenzini Stefania   Attard Luciano   Bonvicini Fiorenza   Bernardi Mauro  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 362-367

Springer Publishing Company

Access to resources Recommend Favorite

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

By Arase Yasuji   Ikeda Kenji   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Akuta Norio   Someya Takashi   Hosaka Tetsuya   Sezaki Hitomi   Kobayashi Mariko   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1090-1094

Springer Publishing Company

Access to resources Recommend Favorite

Development of Myasthenia Gravis due to Treatment of Chronic Hepatitis C with a Combination of Interferon-Alpha and Ribavirin

By  

Digestion, Vol. 75, Iss. 4, 2007-10 ,pp. : 208-209

Karger

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite